Latest Studies

We believe in the power of microdosing and strive to provide our customers with the most accurate and reliable information on the subject. Our dedicated team stays on top of the latest research and trends to ensure we are always offering the best possible products and resources.

We believe in transparency and making informed decisions. That's why we make it a priority to keep our customers informed about the latest scientific research on psilocybin microdosing. Stay ahead of the game and learn about the exciting developments in the field of microdosing.

We understand that microdosing is a personal journey, and everyone's experience is unique. That's why we are here to support and guide you every step of the way. From the latest research to expert advice and personalized recommendations, we are dedicated to helping you achieve your microdosing goals 

Microdosing psychedelics, particularly psilocybin, has gained popularity in recent years as a way to enhance creativity, focus, and emotional well-being. But did you know that scientific research is also exploring the potential of microdosing psilocybin as a medicine? Several studies have investigated the therapeutic benefits of psilocybin microdosing, including its effects on reducing depression and anxiety, enhancing psychological flexibility, and even helping with alcohol addiction. In this section, we've compiled a list of scientific journal articles on psilocybin microdosing as medicine, providing you with the latest research on this fascinating topic.

• Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L. A., Hui, K., ... & Farb, N. A. (2020). Psychedelic microdosing benefits and challenges: an empirical codebook. Harm Reduction Journal, 17(1), 1-10.

• Davis, A. K., Barrett, F. S., & Griffiths, R. R. (2020). Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of Contextual Behavioral Science, 15, 39-45

• Garcia-Romeu, A., Davis, A. K., Erowid, F., Erowid, E., Griffiths, R. R., & Johnson, M. W. (2020). Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of Psychopharmacology, 34(5), 608-615

• Lea, Toby, et al. "Microdosing psychedelics: motivations, subjective effects and harm reduction." International Journal of Drug Policy 75 (2020): 102600.

• Rootman, Joseph M., et al. "Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls." Scientific Reports 12.1 (2022): 11091.

Podcasts can be a great resource for learning more about microdosing psilocybin and its potential benefits. Whether you're new to microdosing or a seasoned practitioner, these podcasts offer insights, tips, and interviews with experts and individuals who have tried microdosing. Here are five great podcasts to check out:

1. Third Wave Podcast - In this podcast, Third Wave founder Paul Austin interviews experts on topics related to psychedelics, including microdosing.
2. The Psychedelic Therapy Podcast - This podcast features interviews with leading researchers, therapists, and advocates in the field of psychedelic therapy, including discussions on microdosing.
3. The Microdose - Hosted by James Fadiman, a pioneer in psychedelic research, this podcast explores various aspects of microdosing and features interviews with experts and individuals who have tried microdosing.
4. Psychedelics Today - This podcast covers a wide range of topics related to psychedelics, including microdosing, with interviews with experts and researchers in the field.
5. The Third Wave Microdose - In this podcast, the Third Wave team shares insights and tips on microdosing, along with interviews with experts and individuals who have tried microdosing.

You can listen to these podcasts on your preferred platform, such as Apple Podcasts or Spotify, and gain a deeper understanding of the potential benefits of microdosing psilocybin.

As a pioneer in the world of microdosing mushrooms, our commitment to excellence, safety, and innovation aligns perfectly with the core values upheld by the CPA.

The Canadian Psychedelic Association is a non-profit organization dedicated to fostering a supportive, ethical, and responsible environment for the burgeoning psychedelic industry in Canada. Comprised of researchers, medical professionals, therapists, cultivators, and other stakeholders, the CPA aims to educate, promote best practices, and advocate for sensible public policy in the field of psychedelics.

We are proud to be part of this dynamic network that encourages collaboration, knowledge-sharing, and the development of industry standards. By adhering to the CPA's guidelines and participating in their initiatives, we ensure that our microdose mushroom products are of the highest quality, produced in compliance with all relevant regulations, and backed by the latest research.

By choosing Brainfuel, you are not only supporting a company that values the power of plant-based medicine but also contributing to the growth of a responsible and sustainable psychedelic industry in Canada. Join us on our journey towards enhanced well-being, personal growth, and the advancement of this revolutionary field.